Literature DB >> 34998968

Association between race/ethnicity and income on the likelihood of coronary revascularization among postmenopausal women with acute myocardial infarction: Women's health initiative study.

Tarryn Tertulien1, Mary B Roberts2, Charles B Eaton3, Crystal W Cene4, Giselle Corbie-Smith5, JoAnn E Manson6, Matthew Allison7, Rami Nassir8, Khadijah Breathett9.   

Abstract

BACKGROUND: Historically, race, income, and gender were associated with likelihood of receipt of coronary revascularization for acute myocardial infarction (AMI). Given public health initiatives such as Healthy People 2010, it is unclear whether race and income remain associated with the likelihood of coronary revascularization among women with AMI.
METHODS: Using the Women's Health Initiative Study, hazards ratio (HR) of revascularization for AMI was compared for Black and Hispanic women vs White women and among women with annual income <$20,000/year vs ≥$20,000/year over median 9.5 years follow-up(1993-2019). Proportional hazards models were adjusted for demographics, comorbidities, and AMI type. Results were stratified by revascularization type: percutaneous coronary intervention and coronary artery bypass grafting(CABG). Trends by race and income were compared pre- and post-2010 using time-varying analysis.
RESULTS: Among 5,284 individuals with AMI (9.5% Black, 2.8% Hispanic, and 87.7% White; 23.2% <$20,000/year), Black race was associated with lower likelihood of receiving revascularization for AMI compared to White race in fully adjusted analyses [HR:0.79(95% Confidence Interval:[CI]0.66,0.95)]. When further stratified by type of revascularization, Black race was associated with lower likelihood of percutaneous coronary intervention for AMI compared to White race [HR:0.72(95% CI:0.59,0.90)] but not for CABG [HR:0.97(95%CI:0.72,1.32)]. Income was associated with lower likelihood of revascularization [HR:0.90(95%CI:0.82,0.99)] for AMI. No differences were observed for other racial/ethnic groups. Time periods (pre/post-2010) were not associated with change in revascularization rates.
CONCLUSION: Black race and income remain associated with lower likelihood of revascularization among patients presenting with AMI. There is a substantial need to disrupt the mechanisms contributing to race, sex, and income disparities in AMI management.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34998968      PMCID: PMC8918000          DOI: 10.1016/j.ahj.2021.12.013

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  42 in total

1.  Understanding racial variation in the use of coronary revascularization procedures: the role of clinical factors.

Authors:  J Conigliaro; J Whittle; C B Good; B H Hanusa; L J Passman; R P Lofgren; R Allman; P A Ubel; M O'Connor; D S Macpherson
Journal:  Arch Intern Med       Date:  2000-05-08

2.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

Authors:  J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

3.  How and why studies disagree about the effects of education on health: A systematic review and meta-analysis of studies of compulsory schooling laws.

Authors:  Rita Hamad; Holly Elser; Duy C Tran; David H Rehkopf; Steven N Goodman
Journal:  Soc Sci Med       Date:  2018-07-20       Impact factor: 4.634

4.  Appropriateness of percutaneous coronary intervention.

Authors:  Paul S Chan; Manesh R Patel; Lloyd W Klein; Ronald J Krone; Gregory J Dehmer; Kevin Kennedy; Brahmajee K Nallamothu; W Douglas Weaver; Frederick A Masoudi; John S Rumsfeld; Ralph G Brindis; John A Spertus
Journal:  JAMA       Date:  2011-07-06       Impact factor: 56.272

Review 5.  Socioeconomic inequalities in access to treatment for coronary heart disease: A systematic review.

Authors:  Sara L Schröder; Matthias Richter; Jochen Schröder; Stefan Frantz; Astrid Fink
Journal:  Int J Cardiol       Date:  2016-05-14       Impact factor: 4.164

6.  Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials.

Authors:  Mordechai Golomb; Björn Redfors; Aaron Crowley; Pieter C Smits; Patrick W Serruys; Clemens von Birgelen; Mahesh V Madhavan; Ori Ben-Yehuda; Roxana Mehran; Martin B Leon; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2020-07-13       Impact factor: 11.195

7.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

8.  Impact Of Ambulance Diversion: Black Patients With Acute Myocardial Infarction Had Higher Mortality Than Whites.

Authors:  Renee Y Hsia; Nandita Sarkar; Yu-Chu Shen
Journal:  Health Aff (Millwood)       Date:  2017-06-01       Impact factor: 6.301

9.  Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Edward P Havranek; Mahasin S Mujahid; Donald A Barr; Irene V Blair; Meryl S Cohen; Salvador Cruz-Flores; George Davey-Smith; Cheryl R Dennison-Himmelfarb; Michael S Lauer; Debra W Lockwood; Milagros Rosal; Clyde W Yancy
Journal:  Circulation       Date:  2015-08-03       Impact factor: 29.690

10.  Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study.

Authors:  Monika M Safford; Evgeniya Reshetnyak; Madeline R Sterling; Joshua S Richman; Paul M Muntner; Raegan W Durant; John Booth; Laura C Pinheiro
Journal:  Circulation       Date:  2020-12-03       Impact factor: 29.690

View more
  1 in total

1.  Meta-Analysis of the Effects of Recombinant Human Brain Natriuretic Peptides on Left Ventricular Remodeling in Patients with Acute Myocardial Infarction.

Authors:  Ping Zhu
Journal:  Comput Math Methods Med       Date:  2022-08-18       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.